Role of Cannabinoids in Multiple Sclerosis

Multiple Sclerosis, Cannabinoids, and Cognition

(2014) Panagiotis Papathanasopoulos et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

(2010) John P Zajicek et al.   BMC Neurology

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

(2009) Javier Palazuelos et al.   BRAIN

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

(2009) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Current Management of Pain Associated with Multiple Sclerosis

(2009) Walter Pöllmann et al.   CNS DRUGS

Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study

(2009) S. Rossi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study

(2009) Claudio Solaro et al.   JOURNAL OF NEUROLOGY

The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis

(2009) P Feys et al.   Multiple Sclerosis Journal

Levels of evidence: Taking Neurology(R) to the next level

(2009) R. A. Gross et al.   NEUROLOGY

A UK consensus on the management of the bladder in multiple sclerosis

(2009) C J Fowler et al.   POSTGRADUATE MEDICAL JOURNAL

Therapeutic potential of cannabis in pain medicine † †Declaration of interest. The authors have received funding from the Medical Research Council and the South West Regional Development Agency.

(2008) R.D. Hosking et al.   BRITISH JOURNAL OF ANAESTHESIA

Adverse effects of medical cannabinoids: a systematic review

(2008) T. Wang et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

The Endocannabinoid System and Multiple Sclerosis

(2008) David Baker et al.   CURRENT PHARMACEUTICAL DESIGN

Invited Article: Lost in a jungle of evidence: We need a compass

(2008) J. French et al.   NEUROLOGY

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

(2007) M D Jhaveri et al.   BRITISH JOURNAL OF PHARMACOLOGY